STRIDES PHARMA SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 846.1 INR | -2.85% |
|
-0.46% | +30.32% |
| May. 10 | Market Heavyweights Lifts Indian Equities to End Week Higher | MT |
| May. 10 | Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia | MT |
Presenter SpeechAbhishek Singhal (Analysts)A very good afternoon, and thank you for joining us...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
846.1
INR
Average target price
830.5
INR
Spread / Average Target
-1.84%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +30.32% | 961M | |
| +22.35% | 44.12B | |
| +22.22% | 22.61B | |
| +17.81% | 15.11B | |
| +15.73% | 13.61B | |
| +57.91% | 13.34B | |
| -8.98% | 6.94B | |
| -0.05% | 6.79B | |
| +14.03% | 5.75B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Transcript : Strides Pharma Science Limited, Q3 2021 Earnings Call, Feb 04, 2021